

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE - Get Free Report) saw a significant decline in short interest in the month of March. As of March 13th, there was short interest totaling 15,745 shares, a decline of 36.0% from the February 26th total of 24,607 shares. Currently, 1.0% of the shares of the company are

The health of the $7 trillion U.S. ETF remains strong, with many advisors and investors pairing ETFs with other investments and new entrants joining the market. BlackRock remains the industry leader and has expanded its lineup with innovative strategies in 2023.

BlackRock is offering target-date exchanged-traded funds aimed at helping people save for their retirement outside of a 401 (K) plan.
SEC filings for ITDE aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.